Videos

“Often you think we’re the victim, but there’s a lot that you can do to be your own advocate and participate in your healing,” says stage four metastatic breast cancer thriver Nalie Agustin.

Expert Dr. Sara Hurvitz discusses why cancer survivors should discuss their risk factors during the COVID-19 pandemic with their healthcare providers.

Genetic testing offers a care team a wealth of knowledge to help them craft treatments, but it also can help match patients to clinical trials for potentially better outcomes.

In the face of the COVID-19 pandemic patients with cancer who are considered to have weakened immune systems need to have a special emphasis placed on their care.

Patients faced with cancer are also faced with tough uphill financial battles, but there are assistance programs that can help.

Having the right understanding and information of a patient’s genetics can not only help treat cancer but also help prevent it.

Understanding a diagnosis is not just something for a patient's care team, the patient needs to understand their diagnosis as well.

Understanding biomarkers specific to breast cancer can guide treatment plans and help families with a history of the disease take preventive measures.

Don’t be worried to get a second opinion — it could save your life.

Here are the latest highlights from the first CURE Hematology Special Edition issue for 2020.

If patients take a deep breath and concentrate on the journey ahead after receiving a diagnosis, they can find a path forward, says one metastatic breast cancer thriver.

At the 2020 CURE® Educated Patient Breast Cancer Summit, oncology nurse Patricia Jakel had the chance to discuss the types of questions patients should be asking their care team.

Genetic and genomic testing is vital for patients with breast cancer and not only do patients need to understand why that is, but their physicians as well.

Get a sneak peek at what’s inside our Winter 2020 issue of Heal Magazine.

Here are the top five CURE® stories for February 2020.

Patients with a compromised immune system are more susceptible to the coronavirus, including those with cancer. Here are four key things patients with cancer should know about the novel coronavirus.

Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.

Here’s a look at what’s inside our 2020 Winter issue.

Treatments for renal cell carcinoma are showing effectiveness in the short term, but with the help of new trials, researchers are looking to expand their impact for long term treatment.

The landscape for patients with renal cell carcinoma could potentially change as the use of immune checkpoint inhibition shows promise for these patients.